James C. Lin
Lawyers
Filters
Hutchison China Meditech Limited $282 Million Secondary Offering
Davis Polk advised the underwriter in connection with a secondary offering of 12,000,000 American Depositary Shares of Hutchison China Meditech Limited (“Chi-Med”), each representing five…
The Export-Import Bank of Korea $1 Billion Notes Offering
Davis Polk advised the underwriters in connection with the SEC-registered Schedule B debt offerings by the Export-Import Bank of Korea (“KEXIM”) of $500 million aggregate principal amount…
YY Inc. $1 Billion Convertible Senior Notes Offering
Davis Polk advised the initial purchasers in connection with a Rule 144A and Regulation S offering by YY Inc. (NASDAQ: YY) of $425 million aggregate principal amount of 0.750% convertible…
Davis Polk Advises Tencent on Its $6 Billion Notes Offering Under Its Global MTN Program
Davis Polk advised Tencent Holdings Limited as English and U.S. law counsel in connection with the upsize and update of its $20 billion global medium-term note program and the offering…
iQIYI, Inc. $1.2 Billion Convertible Senior Notes Offering
Davis Polk advised the initial purchasers in connection with a Rule 144A and Regulation S offering by iQIYI, Inc. of $1.2 billion aggregate principal amount of its 2.00% convertible senior…
UP Fintech Holding Limited Initial Public Offering and NASDAQ Listing
Davis Polk advised the representatives of the underwriters on the SEC-registered initial public offering by UP Fintech Holding Limited (Tiger Trade) of 13,000,000 American Depositary Shares…
Sea Limited Follow-On Offering of American Depositary Shares
Davis Polk advised the representatives of the underwriters in the offering of 69,000,000 American Depositary Shares by Sea Limited for total proceeds of over $1.5 billion, including the…
SP Group Treasury Pte. Ltd. $600 Million Notes Offering
Davis Polk advised the joint lead managers on a Rule 144A/Regulation S offering by SP Group Treasury Pte. Ltd. of $600 million aggregate principal amount of 3.375% notes due 2029 under its…
Davis Polk Advises CStone Pharmaceuticals on Its HK$2.24 Billion (US$285.05 Million) Initial Public Offering
Davis Polk advised CStone Pharmaceuticals in connection with its initial public offering and listing on the Hong Kong Stock Exchange and an international offering in reliance on Rule 144A…
The Korea Development Bank $1 Billion Notes Offering
Davis Polk advised the underwriters in connection with an SEC-registered Schedule B debt offering by The Korea Development Bank of $500 million aggregate principal amount of its 3.00% notes…